Antigen-specific removal of circulating immune complexes

Details Antigen-specific removal of circulating immune complexes Antigen-specific removal of circulating immune complexes

A - Human Necessities

61

M

167/114, 167/129

A61M 1/36 (2006.01) A61K 39/00 (2006.01) G01N 33/564 (2006.01)

Patent

CA 1337112

Extracorporeal perfusion using an immunoadsor- bent material specific for disease-related antigens is used for therapy of the disease state. Antibodies to particular antigens, including tumor antigens, viral antigens, and bacterial antigens, are used to prepare the immunoadsorbent material. Patients suffering from the disease are then treated by removing a flow of blood, separating the blood into plasma cellular components, passing the plasma through the immunoadsor- bent material, recombining the treated plasma and cellular components of the blood, and returning the treated blood to the patient.

552326

Affiliated with

Also associated with

Rating

Antigen-specific removal of circulating immune complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigen-specific removal of circulating immune complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen-specific removal of circulating immune complexes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1303141